Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

$8 Billion Shortfall in Proposed Mining Tax

Zijin Mining Group Calls Off Platmin Congo Acquisition

Goldcorp Inc. to Buy Andean Resources Ltd. for $3.5 Billion

Newcrest Mining Seeking New Mergers and Acquisition

China Metallurgical Group To Construct Iron Ore Mine in WA

Call to Ban Prosperity Mine Proposal Gaining Momentum

Mali Looks to Attract More Mining Investment with New Mining Code

Philex Mining Looks to Invest $5.2b in Philippino Gold Project

National Mining Association Attacks EPA Report on the Polluting Effects of Mountain Top Coal Mining

Lundin Mining Sitting on More Copper Reserves Than it Thought

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.